Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FGES1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,772
Award facts
- Contract value 100% obligated
- $20,772.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,772 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The award, issued on January 21, 2026, with an ultimate completion date of February 11, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion acquisition vehicle established to provide comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial performance as a critical pharmaceutical supplier within the federal military medical supply chain, with numerous delivery orders spanning oncology treatments, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The company's established capacity to fulfill diverse and specialized pharmaceutical requirements, combined with its small business status and consistent contract performance across multiple product categories, positions it as a reliable vendor within the broader $30.3 billion PPV-G GEN V program structure, which utilizes multiple regional prime vendor contractors to support DoD healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FGES1?
SPE2DR26FGES1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FGES1 worth?
The government has obligated $20,772 on SPE2DR26FGES1.
Is contract SPE2DR26FGES1 an order under another contract?
Yes. SPE2DR26FGES1 is a delivery order under SPE2DR25D9312, an indefinite delivery contract.
Was contract SPE2DR26FGES1 competed?
The extent of competition for SPE2DR26FGES1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award